We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
Cap. Flow
+$1.82B
Cap. Flow %
2.24%
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$164M
2
MSFT icon
Microsoft
MSFT
+$157M
3
AMZN icon
Amazon
AMZN
+$75.7M
4
TSLA icon
Tesla
TSLA
+$50M
5
GEHC icon
GE HealthCare
GEHC
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 25.37%
2 Healthcare 13.58%
3 Financials 12.66%
4 Consumer Discretionary 10.75%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBA
1776
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
$2.12M ﹤0.01%
120,634
+3,295
+3% +$59.1K
ASAN icon
1777
Asana
ASAN
$2.13B
$2.11M ﹤0.01%
100,056
+3,227
+3% +$53.5K
HSTM icon
1778
HealthStream
HSTM
$840M
$2.11M ﹤0.01%
77,976
+3,804
+5% +$94.9K
IMKTA icon
1779
Ingles Markets
IMKTA
$1.67B
$2.11M ﹤0.01%
23,793
+668
+3% +$62K
OPI
1780
DELISTED
Office Properties Income Trust
OPI
$2.11M ﹤0.01%
171,390
+8,143
+5% +$125K
LAZR
1781
DELISTED
Luminar Technologies
LAZR
$2.11M ﹤0.01%
21,642
+461
+2% +$48.4K
AGIO icon
1782
Agios Pharmaceuticals
AGIO
$1.93B
$2.1M ﹤0.01%
91,405
+2,137
+2% +$56.8K
IJR icon
1783
iShares Core S&P Small-Cap ETF
IJR
$112B
$2.1M ﹤0.01%
21,719
-19,982
-48% -$2M
AKRO
1784
DELISTED
Akero Therapeutics
AKRO
$2.1M ﹤0.01%
54,871
+3,158
+6% +$141K
TTEC icon
1785
TTEC Holdings
TTEC
$124M
$2.08M ﹤0.01%
55,986
+2,929
+6% +$131K
VIRT icon
1786
Virtu Financial
VIRT
$4.93B
$2.08M ﹤0.01%
109,939
+1,260
+1% +$24.2K
SEB icon
1787
Seaboard Corp
SEB
$4.06B
$2.08M ﹤0.01%
551
-6
-1% -$23.2K
PRVB
1788
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$2.08M ﹤0.01%
86,095
+4,804
+6% +$60.3K
AIV
1789
Aimco
AIV
$383M
$2.07M ﹤0.01%
269,753
+8,314
+3% +$62K
UFCS icon
1790
United Fire Group
UFCS
$1.4B
$2.07M ﹤0.01%
78,085
+3,783
+5% +$108K
SFL icon
1791
SFL Corp
SFL
$1.61B
$2.06M ﹤0.01%
217,328
+7,577
+4% +$74.8K
CEVA icon
1792
CEVA Inc
CEVA
$1.08B
$2.06M ﹤0.01%
67,604
+4,175
+7% +$131K
FLGT icon
1793
Fulgent Genetics
FLGT
$527M
$2.06M ﹤0.01%
65,883
+1,717
+3% +$55.3K
OSPN icon
1794
OneSpan
OSPN
$618M
$2.06M ﹤0.01%
117,458
+5,833
+5% +$87.3K
OFIX icon
1795
Orthofix Medical
OFIX
$419M
$2.04M ﹤0.01%
121,985
+51,820
+74% +$1.01M
OEC icon
1796
Orion
OEC
$409M
$2.04M ﹤0.01%
78,254
+2,057
+3% +$46.5K
CERE
1797
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$2.04M ﹤0.01%
83,722
+3,960
+5% +$116K
THRY icon
1798
Thryv Holdings
THRY
$108M
$2.04M ﹤0.01%
88,414
+4,722
+6% +$106K
AGM icon
1799
Federal Agricultural Mortgage
AGM
$2.56B
$2.03M ﹤0.01%
15,253
+622
+4% +$81.7K
PBI icon
1800
Pitney Bowes
PBI
$2.39B
$2.03M ﹤0.01%
522,124
+35,128
+7% +$148K

Similar funds

RhumbLine Advisers's Q1 2023 Portfolio in Review

As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
  • RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
  • RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
  • RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
  • RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
  • RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
  • RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.

Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.